In middle term-follow-up, the tumor recurred in 11 patients though, almost have received full dose chemotherapy with cisplatin and gemsar (or taxol).
Qua theo dõi trung hạn 36 tháng (6 - 72), 11 bệnh nhân tái phát (46%).